| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
45,691 |
39,524 |
$4.49M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,605 |
12,106 |
$1.10M |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
3,037 |
2,885 |
$354K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,622 |
2,504 |
$332K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,882 |
1,790 |
$216K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,992 |
1,888 |
$207K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,698 |
2,468 |
$144K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,344 |
1,262 |
$141K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,932 |
4,607 |
$110K |
| 92551 |
|
11,453 |
10,801 |
$106K |
| 80061 |
Lipid panel |
7,856 |
7,402 |
$94K |
| 3008F |
|
44,123 |
37,110 |
$93K |
| 93000 |
|
6,172 |
5,816 |
$88K |
| 36415 |
Collection of venous blood by venipuncture |
26,543 |
24,398 |
$79K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
797 |
721 |
$76K |
| 80053 |
Comprehensive metabolic panel |
7,727 |
7,255 |
$70K |
| 90686 |
|
2,902 |
2,682 |
$57K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,416 |
4,096 |
$56K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,546 |
7,053 |
$50K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,148 |
5,768 |
$50K |
| 99051 |
|
7,612 |
6,209 |
$45K |
| 3044F |
|
6,715 |
5,807 |
$38K |
| 86703 |
|
3,013 |
2,811 |
$38K |
| 87899 |
|
3,047 |
2,840 |
$37K |
| 3074F |
|
14,449 |
12,391 |
$37K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
894 |
806 |
$35K |
| 82570 |
|
5,650 |
5,312 |
$27K |
| D1206 |
Topical application of fluoride varnish |
918 |
918 |
$23K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,709 |
2,512 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,685 |
2,481 |
$22K |
| 3078F |
|
10,729 |
9,202 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,100 |
953 |
$21K |
| 96160 |
|
8,182 |
7,732 |
$20K |
| 90670 |
|
765 |
715 |
$16K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
298 |
243 |
$16K |
| 99173 |
|
8,665 |
8,127 |
$15K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
3,094 |
2,834 |
$15K |
| 90651 |
|
635 |
606 |
$14K |
| 90677 |
|
161 |
142 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,150 |
1,052 |
$13K |
| 90698 |
|
591 |
549 |
$13K |
| 99215 |
Prolong outpt/office vis |
87 |
82 |
$12K |
| 90734 |
|
518 |
497 |
$11K |
| 99000 |
|
15,085 |
13,682 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,282 |
1,482 |
$10K |
| 81003 |
|
5,345 |
5,015 |
$10K |
| 90633 |
|
431 |
409 |
$9K |
| G9225 |
Foot exam was not performed, reason not given |
1,093 |
1,032 |
$8K |
| 86592 |
|
2,029 |
1,841 |
$8K |
| S9452 |
Nutrition classes, non-physician provider, per session |
3,428 |
3,142 |
$8K |
| 3079F |
|
3,216 |
2,828 |
$8K |
| 90710 |
|
332 |
317 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
133 |
62 |
$7K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,859 |
2,948 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
256 |
250 |
$6K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,951 |
1,831 |
$5K |
| 90744 |
|
223 |
202 |
$4K |
| 90685 |
|
144 |
142 |
$3K |
| 80050 |
General health panel |
358 |
291 |
$3K |
| 82948 |
|
724 |
627 |
$3K |
| 86580 |
|
494 |
464 |
$3K |
| 90680 |
|
127 |
113 |
$3K |
| 99381 |
|
31 |
24 |
$3K |
| 94760 |
|
1,736 |
1,428 |
$3K |
| 84439 |
|
248 |
244 |
$2K |
| 3075F |
|
734 |
639 |
$2K |
| 82043 |
|
391 |
378 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
212 |
182 |
$2K |
| 87081 |
|
249 |
231 |
$1K |
| 90715 |
|
81 |
74 |
$1K |
| 84436 |
|
294 |
288 |
$1K |
| 90696 |
|
72 |
68 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$1K |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
595 |
573 |
$1K |
| 82607 |
|
136 |
133 |
$1K |
| 3077F |
|
491 |
410 |
$1K |
| 3017F |
|
334 |
312 |
$956.23 |
| 90662 |
|
123 |
98 |
$833.51 |
| 3080F |
|
424 |
360 |
$770.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,729 |
1,606 |
$642.80 |
| 2015F |
|
74 |
74 |
$627.50 |
| 99188 |
|
370 |
352 |
$451.50 |
| 4551F |
|
97 |
94 |
$412.00 |
| 98960 |
|
181 |
158 |
$410.91 |
| 87807 |
|
31 |
31 |
$370.77 |
| 81002 |
|
140 |
88 |
$277.63 |
| G8399 |
Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed |
797 |
766 |
$265.74 |
| 99443 |
|
55 |
51 |
$263.62 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
229 |
221 |
$132.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
558 |
522 |
$124.01 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
26 |
24 |
$110.00 |
| 1111F |
|
292 |
271 |
$106.89 |
| 3046F |
|
31 |
25 |
$106.00 |
| 81025 |
|
18 |
16 |
$95.76 |
| 4040F |
|
199 |
195 |
$90.74 |
| 81015 |
|
317 |
296 |
$56.81 |
| G8482 |
Influenza immunization administered or previously received |
164 |
160 |
$41.14 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
286 |
284 |
$0.00 |
| 36416 |
|
15 |
13 |
$0.00 |
| G0245 |
Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education |
12 |
12 |
$0.00 |
| G8400 |
Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given |
92 |
87 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
12 |
12 |
$0.00 |